Frequency of and risk factors for potentially inappropriate medication use in Parkinson’s disease
Age and Ageing2020Vol. 49(5), pp. 786–792
Citations Over TimeTop 20% of 2020 papers
Danielle S. Abraham, Thanh Phuong Pham Nguyen, Sean Hennessy, Daniel Weintraub, Shelly L. Gray, Dawei Xie, Allison W. Willis
Abstract
PIM prescriptions are not uncommon in PD, particularly for medications that can exacerbate cognitive impairment. Future research will examine underlying drivers of sex and other disparities in PIM prescribing. Additional studies are needed to understand the impact of PIMs on disease symptoms, healthcare utilisation and patient outcomes.